Although Onc.Ads encoding GM-CSF have produced clinical benefits in patients with various malignancies (e.g., ovarian cancer, breast cancer, lung cancer) [62], GM-CSF also promotes the immunosuppressive activity of myeloid-derived suppressor cells (MDSCs) in malignant glioma [77]. The gene discussed is CSF2; the disease is lung carcinoma.